STOCK TITAN

LXEO (NASDAQ: LXEO) Form 144 reports 3,861 shares tied to vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LXEO submitted a Form 144 reporting the proposed sale of 3,861 common shares tied to restricted stock vesting on 02/17/2026. The filing lists Fidelity Brokerage Services LLC as a broker/firm with a trade date of 02/18/2026 and indicates NASDAQ as the market.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does LXEO's Form 144 report?

The filing reports a proposed sale of 3,861 common shares related to restricted stock vesting on 02/17/2026. It lists Fidelity Brokerage Services LLC as the broker and references NASDAQ with a trade date of 02/18/2026.

Who is listed as the broker on the LXEO Form 144?

Fidelity Brokerage Services LLC is named as the broker/firm on the filing. The entry shows the firm address and a trade-related date of 02/18/2026 in connection with the reported securities transaction.

What type of securities and transaction are shown for LXEO?

The filing concerns common shares and identifies the reason as restricted stock vesting with an issuer designation. The vesting date recorded is 02/17/2026, and the file references proposed sale activity.

Which market is indicated for the reported LXEO shares?

The filing specifies NASDAQ as the market for the transaction and lists a broker trade-related date of 02/18/2026. The document does not state execution details beyond those entries.
Lexeo Therapeutics Inc

NASDAQ:LXEO

LXEO Rankings

LXEO Latest News

LXEO Latest SEC Filings

LXEO Stock Data

459.09M
67.58M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW YORK